中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
27期
73-74
,共2页
选择性动脉栓塞%原发性肝癌破裂出血%并发症
選擇性動脈栓塞%原髮性肝癌破裂齣血%併髮癥
선택성동맥전새%원발성간암파렬출혈%병발증
Selective artery embolization%Primary liver cancer rupture hemorrhage%Complications
目的 探讨选择性动脉栓塞治疗原发性肝癌破裂出血的临床应用效果.方法 在医院2014年11月~2015年8月诊治的原发性肝癌破裂出血患者中抽取63例作研究对象,采取随机数字法将本组研究对象分为观察组(n=32)和对照组(n=31),观察组采取选择性动脉栓塞治疗,对照组采取纱布填塞缝扎止血术治疗,对比两组患者并发症发生率和复发率.结果 观察组的并发症发生率为3.13%,其复发率为0;对照组的并发症发生率为12.90%,其复发率为12.90%;两组患者并发症发生率和复发率的组间比较差异有统计学意义(均P<0.05).结论 选择性动脉栓塞治疗原发性肝癌破裂出血的临床应用效果确切,患者无严重并发症,且复发率低.
目的 探討選擇性動脈栓塞治療原髮性肝癌破裂齣血的臨床應用效果.方法 在醫院2014年11月~2015年8月診治的原髮性肝癌破裂齣血患者中抽取63例作研究對象,採取隨機數字法將本組研究對象分為觀察組(n=32)和對照組(n=31),觀察組採取選擇性動脈栓塞治療,對照組採取紗佈填塞縫扎止血術治療,對比兩組患者併髮癥髮生率和複髮率.結果 觀察組的併髮癥髮生率為3.13%,其複髮率為0;對照組的併髮癥髮生率為12.90%,其複髮率為12.90%;兩組患者併髮癥髮生率和複髮率的組間比較差異有統計學意義(均P<0.05).結論 選擇性動脈栓塞治療原髮性肝癌破裂齣血的臨床應用效果確切,患者無嚴重併髮癥,且複髮率低.
목적 탐토선택성동맥전새치료원발성간암파렬출혈적림상응용효과.방법 재의원2014년11월~2015년8월진치적원발성간암파렬출혈환자중추취63례작연구대상,채취수궤수자법장본조연구대상분위관찰조(n=32)화대조조(n=31),관찰조채취선택성동맥전새치료,대조조채취사포전새봉찰지혈술치료,대비량조환자병발증발생솔화복발솔.결과 관찰조적병발증발생솔위3.13%,기복발솔위0;대조조적병발증발생솔위12.90%,기복발솔위12.90%;량조환자병발증발생솔화복발솔적조간비교차이유통계학의의(균P<0.05).결론 선택성동맥전새치료원발성간암파렬출혈적림상응용효과학절,환자무엄중병발증,차복발솔저.
Objective To investigate the clinical application of selective arterial embolization in the treatment of primary hepatic carcinoma rupture.Methods In the hospital from November 2014 to August 2015,63 cases of patients with primary hepatic carcinoma rupture hemorrhage were selected as the research object. They were divided into observation group(n=32)and control group(n=31). The observation group was treated with selective arterial embolization. The control group was treated with gauze packing suture. The incidence and recurrence rate were compared between the two groups.Results The complication rate was 3.13% in the observation group,the recurrence rate was 0. The control group was 12.90%,the recurrence rate was 12.90%,the incidence of complications and the recurrence rate of the two groups were statistically significant(P<0.05).Conclusion Selective arterial embolization in the treatment of primary hepatic carcinoma rupture and bleeding of the clinical application effect is exact,patients without serious complications,and the recurrence rate is lower.
